Forecasting Returns When Patents Expire

From 2011 to 2015, patent exclusivity will expire for drugs totaling more than $140 billion in sales. This staggering number has drawn much of the industry’s attention to the impact on top-line sales. Yet the risk of unexpected product returns […]

Read More

The Changing Face of Today’s PAPs

Established to provide access to critical therapies for patients who cannot afford to pay, and to support the physicians who serve them, charitable patient-assistance programs (PAPs) sponsored by drug manufacturers have become an essential component in the healthcare safety net. […]

Read More

The View from Chain Drug Stores

The 2010-2011 NACDS Chain Pharmacy Industry Profile is now available from the Alexandria, VA, trade association, and as in past years, it brings together a wealth of information about retail drug distribution channels and reimbursement trends. Perhaps the most surprising […]

Read More